Nitric oxide synthase (NOS) and arginase have been shown to regulate nitric oxide (NO) production reciprocally in genital tissues. In animal models, NO is an important regulator of vaginal blood flow and vaginal wall contractility. In this study, we investigated the modulation of NOS and arginase activities by estrogens and androgens in the proximal and distal rabbit vagina. In intact control animals, total NOS activity was higher in the proximal (528 7 78 pmol/mg protein) than the distal (391 7 44 pmol/mg protein) vagina. However, arginase activity was higher in the distal (206 7 8 nmol/mg protein) than the proximal (64 7 5 nmol/mg protein) vagina. Ovariectomy enhanced NOS activity in the proximal but not distal vagina with concomitant decrease in arginase activity in both the proximal and distal vagina. In ovariectomized rabbits, replacement with 5a-dihydrotestosterone (DHT) or D5-androstenediol (Adiol) increased NOS activity beyond that observed in ovariectomized rabbits receiving vehicle. In contrast, DHT and Adiol treatment reduced arginase activity more than that of the ovariectomized rabbits receiving vehicle. Testosterone exhibited inconsistent effects on NOS and arginase activity in the distal and proximal vagina. Estradiol replacement in ovariectomized animals reduced NOS activity in the proximal vagina down to levels that were comparable to intact control animals. However, estradiol positively modulated arginase activity in the distal vagina. Western blot analyses indicated that in the proximal vagina, neural NOS protein levels paralleled the changes observed in enzyme activity. These observations suggest that steroid hormones differentially regulate NOS and arginase activities of the proximal and distal regions of the vagina. Although estrogen treatment reduced total NOS activity in proximal vagina, estrogens are known to enhance vaginal blood flow. This paradoxical observation may be explained by differential regulation of n-NOS and e-NOS in the proximal and distal vagina. We suggest that changes in vaginal blood flow and compliance may depend on the endocrine status and the levels of circulating androgens and estrogens.
Introduction
Female genital sexual arousal is a physiological process modulated by the hormonal milieu and neurovascular input, resulting in increased genital blood flow, increased vaginal lubrication and length, and decreased vaginal luminal pressure. [1] [2] [3] [4] Sex steroid hormones play an important role in reproductive physiology. However, the role of estrogens and androgens in female genital sexual arousal remains poorly understood. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In menopause, reduced circulating estrogens may be associated with vaginal dryness, irritation, genital pain, diminished sexual desire, decreased genital sensation and difficulty achieving orgasm. 15, 16 Further, decreased pelvic blood flow resulting in decreased congestion in genital tissue during sexual arousal, increased clitoral fibrosis, thinning of vaginal epithelial layers and decrease in vaginal submucosal vasculature are attributed in part to loss of estrogens. 7, 12, 14, [17] [18] [19] Estrogen replacement in women has been reported to increase pelvic blood flow and restore the structural and functional integrity of vaginal tissue. [12] [13] [14] 18 Although androgens are critical for development, growth and maintenance of secondary sex characteristics, 5, 6 their role in female genital sexual arousal remains controversial. Treatment of ovariectomized animals with testosterone or 5-a-dihydrotestoster-one (DHT) increased vaginal weight and mucification in the absence of estrogen replacement. 20, 21 Dehydroepiandrosterone (DHEA), applied topically to the vagina of ovariectomized rats, showed significant effects on vaginal epithelium. 22 The effects of DHEA were attributed to conversion of DHEA to estrogens by vaginal cells. These observations suggest that androgens modulate vaginal physiology.
The nitric oxide synthase (NOS)/cGMP pathway has been implicated in regulating vaginal smooth muscle contractility and blood flow. 23, 24 We have recently reported on the physiological role of NO in modulating vaginal blood flow 25 employing inhibitors of NOS and guanylyl cyclase. We demonstrated that the NO/cGMPathway modulates pelvic nervemediated blood flow in the vagina. Furthermore, the activity of NOS has been shown to be modulated by estrogens [26] [27] [28] [29] [30] and androgens. [31] [32] [33] [34] NOS activity may also be regulated by limiting the availability of the substrate L-arginine by the enzyme arginase, which metabolizes L-arginine to urea and orni-thine. 35 If arginase activity is regulated by steroid hormones, it would suggest that steroid hormones could also regulate NOS in an indirect manner. A recent study by Cama et al 36 showed that inhibition of arginase improved vaginal blood flow in the animal model. Thus, NOS and arginase could serve as biochemical markers for assessing androgenic or estrogenic activity of sex steroid hormones in the vagina. This study was undertaken to determine differential regulation of total NOS and arginase activities in the proximal and distal vagina by estrogen or androgen replacement in the ovariectomized rabbit model.
Experimental

Animals
All protocols were approved by the Institutional Animal Care and Use Committee at Boston University School of Medicine. Female New Zealand White rabbits (3.5-4.0 kg) were divided into several groups (5 animals per group) and kept either intact (control; C) or ovariectomized. At 2 weeks postovariectomy, animals were treated for a 2-week period with vehicle (polyethylene glycol; V), testosterone (T), DHEA, DHT, D5-3b, 17b androstenediol (Adiol), estradiol (E), a combination of estradiol and testosterone (E+T) or estradiol plus progesterone (E+P). Hormonal treatment of ovariectomized animals was carried out by implanting osmotic infusion pumps (model 2002; Alzet, Palo Alto, CA, USA) subcutaneously between the scapulas in a sterile manner. The concentration of the steroid was calculated so that the pump would deliver estradiol at a rate of 200 mg/day and androgens or progesterone at a rate of 100 mg/day. For ovariectomized animals undergoing replacement with E+T or E+P, two pumps were implanted. In this study, our objective was to determine the effects of ovariectomy and replacement with a single dose of sex steroid hormone on vaginal NOS and arginase. To this end, we did not attempt to investigate a range of dose-responses to steroid hormones. However, we chose doses of hormones estimated to provide plasma hormone concentrations between 20 and 50 nM in the rabbit.
Vaginal tissue dissection
The uterovaginal tract was removed en bloc, the vaginal tissue was dissected, cleaned of mesenteric tissue and cut open longitudinally. A squamocolumnar junction located between the upper and lower vagina was identified and used as a divide between upper (proximal) and lower (distal) regions. 37 Proximal and distal vaginal tissues were frozen in liquid nitrogen and pulverized. The tissue powder from each group of animals was pooled and stored at À701C for biochemical assays.
Determination of total (neural and endothelial) NOS activity in rabbit vaginal tissue extracts
Total NOS activity (neural-NOS (n-NOS) and endothelial-NOS (e-NOS) in the tissue extract was determined by conversion of L-[ 14 C]arginine to [ 14 C]citrulline, as described previously. [38] [39] [40] Briefly, aliquots of the tissue extract were incubated with tetrahydrobiopterin (3 mM), calmodulin (30 U/ ml), L-arginine (50 mM), L-[ 14 C]arginine (2 mCi/ml), NADPH (2 mM) and CaCl 2 (1 mM) at 371C for 45 min or 21C for 45 min. Non-specific enzymatic activity was determined in parallel samples incubated with 300 mM of L-NAME. Citrulline was separated from arginine using 1 ml columns of AG50W-X8 resin (Bio-Rad Laboratories, Hercules, CA, USA) and quantified by scintillation spectroscopy. Citrulline production was normalized to total soluble protein in the tissue. The activity measured in the presence of the inhibitor L-NAME was subtracted from the total activity to account for only the specific NOS activity. It should be noted that the total activity measured in this assay reflects both n-NOS and e-NOS activities. Based on preliminary experiments, we found that removal of endogenous arginine by ion exchange chromatography did not influence the measured activity. Similar observations were reported in rabbit vagina tissue extracts. 27 Further, we found that inducible NOS activity (calciumNitric oxide synthase and arginase in the vagina AM Traish et al independent) in the vagina of ovariectomized animals comprised less than 10% of the total activity, in agreement with previous reports. 41 To this end, we did not pursue measurements of iNOS activity in this study.
Arginase activity in rabbit vaginal tissue
Crude tissue extracts were derived from homogenates of rabbit vaginal tissue. Arginase enzyme activity in cytosolic extracts of vaginal tissue was assessed by the method of Rü egg and Russell, as previously described. 35 Briefly, 10 ml of tissue extract (triplicate aliquots) was incubated in buffer (75 mM glycine, pH 9.0, 0.25 mM MnCl 2 ) containing 300 000 dpm of [ 14 C-guanidino]-L-arginine (51.5 mCi/mmol; NEN Life Science Products, Boston, MA, USA), 4 mM of unlabelled L-arginine in a final volume of 100 ml. Samples were incubated for 60 min at 371C and reactions were terminated by the addition of 400 ml of 0.25 M acetic acid (pH 4.5), 7 M urea, 10 mM L-arginine. After the addition of 500 ml of water, samples were passed through a 0.5 ml column of Dowex 50W-X8 resin (Bio-Rad Laboratories, Hercules, CA, USA). Tubes were rinsed twice with 500 ml of water and both rinses were poured onto the columns. Columns were washed with an additional 1 ml of water and all effluent was collected in 20-ml vials. After the addition of 16 ml of Liquiscint (National Diagnostics, Atlanta, GA, USA), radioactivity was quantified by liquid scintillation spectroscopy. Urea production (pmol/min) was normalized to total soluble protein in the tissue.
Determination of neural n-NOS protein expression by Western blot analyses
Protein expression of n-NOS in vaginal tissue was determined by Western blot analyses, using isoformspecific monoclonal antibodies (Transduction Research, Paducah, KY, USA), as described by Traish et al. 39 Rabbit proximal or distal vaginal tissue powder was homogenized in 20 mM HEPES buffer (pH 7.2) containing 0.32 M sucrose, 0.5 mM EDTA and 1 mM DTT, and a cocktail of enzyme inhibitors including phenylmethyl sulfonyl fluoride, aprotinin, leupeptin, pepstatin and bacitracine. 42 The homogenates were centrifuged at 800 g for 30 min at 41C to obtain crude cytosolic extracts. Aliquots of each extract were assayed for protein concentration by the method of Lowry. Identical amounts of protein (100 mg total protein/lane) from each extract were electrophoresed on 7.5% SDS polyacrylamide gels. Following transfer to nitrocellulose membranes, samples were incubated with mouse anti-rat n-NOS monoclonal antibody. The membranes were washed and incubated with horseradish peroxidase-linked goat anti-mouse IgG (secondary antibody, Pierce Chemical Co., Rockford, IL, USA). Membranes were developed with an enhanced chemiluminescence (ECL) kit and exposed to autoradiography film to obtain visible bands at 160 kDa. Rat pituitary lysate was used as positive control (10 mg/lane; rat neural n-NOS). The band intensities were quantified by scanning. It should be noted that this assay provides estimate of n-NOS only.
Data analysis
Data were subjected to ANOVA. If the ANOVA P-value was less than 0.05, multiple paired comparisons were performed using the Tukey-Kramer test. 43 Data were considered to be significantly different when the two-tailed P-value was less than 0.05.
Results
Effects of androgens on total NOS (e-NOS and n-NOS) activities in proximal and distal rabbit vagina
In tissue from control animals, total NOS activity was higher in the proximal (528778 pmol/mg protein) versus the distal vagina (391744 pmol/mg protein). As shown in Figure 1 , ovariectomy enhanced total NOS activity in the proximal vagina, but with little changes in the distal vagina. Treatment of ovariectomized animals with testosterone, DHT or Adiol further increased total NOS activity in the proximal vagina with DHEA having no significant effect. In the distal vagina, no significant changes in total NOS activity were observed by ovariectomy or treatment with T or DHEA. However, treatment with DHT or Adiol produced significant increase in total NOS activity.
Effects of estrogen on total NOS activity in proximal and distal rabbit vagina As shown in Figure 2 , treatment of ovariectomized animals with estradiol with or without T or P decreased NOS activity in the proximal vagina relative to vehicle-treated, ovariectomized animals and normalized values relative to control. No signiNitric oxide synthase and arginase in the vagina AM Traish et al ficant changes were observed in the distal vagina with estradiol treatment. This observation suggests that estrogens differentially regulate e-NOS and n-NOS activities in the proximal and distal vagina. This may have an important implication in the physiological function of these two compartments.
Effects of androgens and estrogen on n-NOS protein expression in proximal and distal rabbit vagina n-NOS protein expression in the proximal vagina was increased by ovariectomy and androgen treatment, but was reduced by estrogen treatment (Figure  3a and b) . Treatment of ovariectomized animals with androgens (DHT or Adiol) resulted in increased NOS protein expression in the proximal vagina (Figure 3a) . No differential changes were observed in the distal vagina with androgen or estrogen treatment (Figure 3c ). Analyses of optical density from several experiments showed consistent trends of reduced expression with estrogens and increased expression with androgens; however, no statistical significance was reached.
Effects of androgens on arginase activity in rabbit vagina
Arginase activity was more predominant in the distal (20678 nmol/mg protein) than in the proximal (6475 nmol/mg protein) vagina. Ovariectomy reduced arginase activity in proximal and distal vagina (Figure 4) . Treatment of ovariectomized animals with DHEA, DHT or Adiol further reduced arginase activity in the distal and proximal vagina. Effects of E, on NOS activity in rabbit proximal and distal vagina. Proximal and distal vaginal tissues were obtained from intact animals (C) or ovariectomized animals treated with V, E, E+T or E+P. The tissues were processed for NOS activity as described in Figure 1 . Data are the mean7s.e.m. of three independent assays. *Po0.05 versus control; + Po0.05 versus vehicle.
Nitric oxide synthase and arginase in the vagina AM Traish et al Interestingly, treatment with T produced an increase in arginase activity in the proximal vagina while decreasing arginase activity in the distal vagina.
Effects of estrogen on arginase activity in rabbit vagina
Treatment of ovariectomized animals with estradiol alone or in combination with T or P resulted in significantly increased arginase activity in the distal vagina ( Figure 5 ), whereas in the proximal vagina, estradiol replacement with or without T did not change arginase activity in ovariectomized animals. E in combination with P resulted in reduced arginase activity compared to vehicle-treated ovariectomized animals.
Discussion
Nitric oxide (NO) has been recognized as a mediator of nonadrenergic noncholinergic neurotransmission in many tissues, including the urogenital organs, and the role of NO/cGMP in modulating clitoral and vaginal function has been the subject of several studies. 23, [26] [27] [28] [29] [30] 41, [44] [45] [46] Recent in vitro organ bath studies 44 have shown that EFS elicited NANC relaxation responses in the rabbit clitoral corpus cavernosum smooth muscle and these responses are inhibited with L-NAME and ODQ, suggesting a role for NO/cGMP pathway in clitoral physiology. Studies with rabbit vaginal strips in organ bath studies 47 have suggested that the NANC neurotransmitter does not involve NO. On the other hand, Giraldi et al 23 presented data from organ bath studies in rat vagina suggesting a key role for the NO/cGMP pathway in vaginal smooth muscle relaxation. However, neither the studies in the clitoris 44 nor that of the vagina 23,40 demonstrated changes in blood flow in response to NO in vivo. Min et al 24 showed that in the animal model, administration of sildenafil enhanced vaginal and clitoral blood flow in response to pelvic nerve stimulation. This observation lends further support In this study, we demonstrated that NOS and arginase are differentially distributed among the two distinct anatomic regions of the rabbit vagina. Total NOS (n-NOS and e-NOS) activities were higher in proximal than in distal vagina. Arginase activity, however, was greater in distal than in proximal vagina. The physiological significance for this unique anatomical distribution of these enzymes, in this animal model, is unknown at present.
Ovariectomy enhanced total NOS activity in the proximal vagina with concomitant decrease in arginase activity in the proximal and distal vagina, suggesting differential regulation of these enzymes by sex steroid hormones in the various anatomical regions of the rabbit vagina. Treatment of ovariectomized animals with T resulted in increased expression and activity of total NOS in the proximal vagina but not in the distal vagina. In contrast, treatment with DHT resulted in increased expression and activity of total NOS in both the proximal and distal vagina. Interestingly, treatment of ovariectomized animals with Adiol increased total NOS activity in proximal and distal vagina, similar to that obtained with DHT. These observations suggest that Adiol may be converted into DHT and modulates NOS activity in the vagina via an androgenic mechanism.
Treatment of ovariectomized animals with E or E combined with T or P normalized NOS activity in the proximal vagina, to that obtained in control animals, while little or no effect was observed in the distal vagina. The downregulation of total NOS activity by estrogens in the proximal vagina is consistent with those reported previously [25] [26] [27] [28] in vagina of the rat and rabbit models. These observations further suggest that in the proximal vagina, total NOS activity is modulated by androgens and estrogens in a reciprocal manner.
n-NOS protein expression in the proximal and distal vagina paralleled enzymatic activity. Ovariectomy and androgen treatment increased n-NOS protein expression in the proximal vagina but not in the distal vagina. Estrogen treatment of ovariectomized animals decreased protein expression in the proximal vagina. It remains to be determined if e-NOS isoform is equally regulated by estrogen and androgens in proximal and distal vagina.
Vaginal arginase activity was reduced by ovariectomy and upregulated by estrogen replacement in the distal vagina, suggesting that arginase is under regulation by estrogen hormones. Treatment of ovariectomized animals with DHEA, Adiol or DHT resulted in decreased arginase activity in the proximal and distal vagina. Interestingly, treatment with testosterone increased arginase activity in the proximal vagina but not in the distal vagina. At present, we do not know why T produced different effects from those obtained with Adiol or DHT. Treatment of ovariectomized animals with E or E in combination with T or P increased arginase activity in the distal vagina. These observations suggest that, in vaginal tissue, arginase activity is modulated by androgens and estrogens in a tissue-and regionspecific manner.
It has been suggested that D5-Adiol mediates its activity by binding to the estrogen and androgen receptors. If D5-Adiol binds to estrogen receptors and mediates estrogen-dependent activity, it would be expected to produce similar effects to those obtained by E treatment, namely reduction of NOS activity and increased arginase activity. To the contrary, the data presented here show that D5-Adiol produced effects similar to those obtained with 5a-DHT. These observations indicate that D5- Figure 5 Effects of estadiol on arginase activity in rabbit proximal and distal vagina. Proximal and distal vaginal tissues were obtained from intact or ovariectomized animals (see Figures  1 and 2 ). The tissues were processed for arginase activity as described in Figure 4 . Data are the mean7s.e.m. of three independent assays. *Po0.05 versus control; + Po0.05 versus vehicle.
Nitric oxide synthase and arginase in the vagina AM Traish et al
Adiol acted specifically as an androgen in the rabbit vagina. Previous work from this laboratory and others indicated that the NO/cGMP pathway may be involved in increasing vaginal blood flow and vaginal wall compliance. 23224 Recent studies have shown that the NO/cGMP pathway is critical in modulating pelvic nerve-stimulated vaginal blood flow in the rabbit model. 25 Thus, understanding the regulation of NOS activity and other factors that may affect this pathway is of physiological importance in peripheral sexual arousal.
Yoon et al 30 have demonstrated increased clitoral and vaginal e-NOS and n-NOS protein expression and activity in ovariectomized rabbits, and expression and activity of NOS was reduced by estrogen administration. Since pelvic nerve-stimulated blood flow to the clitoris and vagina requires estrogen priming, 45 it remains unclear how changes in NOS expression and activity in response to estrogens correlate with blood flow in these genital organs.
The observations that estrogens reduced NOS activity in the proximal vagina may appear paradoxical in light of the important role of estrogens in regulating vaginal blood flow. This would suggest that either NO is not a key mediator of blood flow in the vagina or that the effect of estrogens on NOS is counterbalanced by other neurotransmitters in vivo. Alternatively, the anatomical regional distribution of NOS and arginase may explain, in part, the fact that estrogens reduce total NOS activity in the proximal vagina but not in the distal vagina. Thus, enhanced vaginal blood flow by estrogen may be mediated by activation of e-NOS in the distal vagina, and this differential regulation is masked by changes in NOS isoforms from neural, epithelial smooth muscle and endothelial origins. Neither the studies by Al-Hijji and co-workers [26] [27] [28] [29] nor those by Yoon et al 30 examined NOS isoforms in the two subregions of the rabbit vagina. Thus, differential regulation of e-NOS by sex steroid hormones in the proximal and distal vagina remains to be established.
The rabbit vagina is comprised of two distinct anatomical regions, an upper (proximal) region which represents 2/3 of the length of the vagina and which is lined by a single layer of columnar epithelium, and a lower 1/3 (distal) region of the vagina characterized by squamous epithelium. 37 This unique structure of the upper vagina is thought to be important as a reservoir for spermatozoa and in maintaining their viability. The distal vagina serves the coital function.
Based on the data presented in this study and the anatomical distinctions in the proximal and distal vagina, we speculate that estrogens, while downregulating total NOS activity in the proximal vagina, may also upregulate expression and activity of blood vessels e-NOS in the distal vagina. This would result in increased vasodilation of blood vessels in the distal vagina and enhanced blood flow and vaginal vasocongestion. However, changes in e-NOS activity in the distal vagina may be confounded by the relative abundance of NOS isoforms from various cellular elements (eg epithelial, smooth muscle, neural and endothelial). This research question needs to be clarified by future studies on the cellular and regional distribution of NOS isoforms in the proximal and distal regions of the vagina using immunohistochemical techniques or selective inhibitors of varying NOS isoforms.
In summary, we have characterized the distribution of NOS and arginase activities in the proximal and distal rabbit vagina and evaluated the effects of sex steroid hormone deprivation and replacement on these enzymes. Androgens enhance total NOS activity in the proximal and distal vagina and reduce arginase activity. Estrogens reduce total NOS activity in the proximal vagina and increase arginase activity in the distal vagina. These observations suggest that anatomical distribution of these key metabolic mediators and the circulating levels of androgens and estrogens may modulate the changes in vaginal blood flow and compliance.
